Eurocare 4 Survival Analysis 1995 - 1999
Cancer Site
lip
skin melanoma
tongue
breast
major salivary gland
cervix
oral cavity
corpus uteri
oropharynx
ovary
nasopharynx
vagina and vulva
hypopharynx
prostate
head and neck
testis
esophagus
penis
stomach
urinary bladder
small intestine
kidney
colon
choroid, melanoma
rectum
brain
colon and rectum
thyroid
liver, primary
non hodgkin lymphoma
biliary tract
hodgkin disease
pancreas
multiple mieloma
nasal cavities
ALL
larynx
CLL
lung,bronchus,trachea
AML
pleura
CML
bone
leukemia
soft tissue
All Sites
Population
Denmark
Finland
Iceland
Norway
Sweden
Ireland
UK England
UK Northern Ireland
UK Scotland
UK Wales
Austria
Belgium
France
Germany
Netherlands
Switzerland
Italy
Malta
Portugal
Slovakia
Slovenia
Spain
Czech Republic
Poland
EUROPE
Age Class
15-44
15-54
All ages 15-99
45-54
55-64
65-74
75-99
75-84
85-99
ICSS standard
Time from diagnosis
One year
Two years
Three years
Four years
Five years
Sex
Men
Women
Men & Women
Period of Diagnosis
1995 - 1999
Output Indicators
Number of cases
Observed Survival, Interval (OSI)
Relative Survival, Interval (RSI)
Relative SE's, Interval (RSEI)
Alive at Start
Observed Survival, Cum (OSC)
Relative Survival, Cum (RSC)
Relative SE's, Cum (RSEC)
Dead
Expected Survival, Interval (ESI)
Observed SE's, Interval (OSEI)
RSC: Lower bound (95% CI)
Lost to Follow Up
Expected Survival, Cum (ESC)
Observed SE's, Cum (OSEC)
RSC: Upper bound (95% CI)